---
title: "Michael Burry 将辉瑞、Molina 医疗和哈利伯顿作为对冲通胀的目标"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/286619269.md"
description: "迈克尔·伯里已投资于辉瑞、Molina 医疗和哈利伯顿，理由是它们的盈利稳定性和抗通胀能力。辉瑞提供高额股息和强大的药物研发管线，Molina 预计将恢复，哈利伯顿则受益于油价上涨。然而，潜在的经济衰退带来了风险，尽管当前的估值表明下行空间有限"
datetime: "2026-05-15T21:37:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286619269.md)
  - [en](https://longbridge.com/en/news/286619269.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286619269.md)
---

# Michael Burry 将辉瑞、Molina 医疗和哈利伯顿作为对冲通胀的目标

Burry’s new picks: Michael Burry bought Pfizer, Molina Healthcare, and Halliburton for their earnings stability, pricing power, and inflation resilience. Sector advantages: Pfizer offers a high dividend and drug pipeline, Molina stands to rebound post-trough year, and Halliburton gains from oil price recovery. Risks ahead: A recession could pressure all three stocks, but valuations already reflect significant downside risk.

### 相关股票

- [PFE.US](https://longbridge.com/zh-CN/quote/PFE.US.md)
- [MOH.US](https://longbridge.com/zh-CN/quote/MOH.US.md)
- [HAL.US](https://longbridge.com/zh-CN/quote/HAL.US.md)
- [IEZ.US](https://longbridge.com/zh-CN/quote/IEZ.US.md)
- [XES.US](https://longbridge.com/zh-CN/quote/XES.US.md)
- [IHE.US](https://longbridge.com/zh-CN/quote/IHE.US.md)
- [CURE.US](https://longbridge.com/zh-CN/quote/CURE.US.md)
- [OIH.US](https://longbridge.com/zh-CN/quote/OIH.US.md)
- [XLV.US](https://longbridge.com/zh-CN/quote/XLV.US.md)
- [IHF.US](https://longbridge.com/zh-CN/quote/IHF.US.md)
- [XOP.US](https://longbridge.com/zh-CN/quote/XOP.US.md)
- [IXJ.US](https://longbridge.com/zh-CN/quote/IXJ.US.md)
- [VHT.US](https://longbridge.com/zh-CN/quote/VHT.US.md)

## 相关资讯与研究

- [辉瑞在第二阶段取得强劲的积极结果后，推进关键的儿童肺炎球菌疫苗项目 | PFE 股票新闻](https://longbridge.com/zh-CN/news/287035698.md)
- [英国家庭能源账单 7 月预计涨 13%，或创 2023 年来最大涨幅](https://longbridge.com/zh-CN/news/286899690.md)
- [百时美施贵宝向 3 万名员工全面开放 Anthropic 公司 Claude](https://longbridge.com/zh-CN/news/287085684.md)
- [瑞银上调爵士制药评级：核心业务韧性强劲，新药 Ziihera 成增长引擎](https://longbridge.com/zh-CN/news/286920691.md)
- [Scholar Rock 将出席杰富瑞全球医疗保健大会，聚焦 SMA 新药 apitegromab 关键审批](https://longbridge.com/zh-CN/news/287069556.md)